ES2084150T3 - Aminoacidos, peptidos o sus derivados asociados a las grasas. - Google Patents

Aminoacidos, peptidos o sus derivados asociados a las grasas.

Info

Publication number
ES2084150T3
ES2084150T3 ES91901249T ES91901249T ES2084150T3 ES 2084150 T3 ES2084150 T3 ES 2084150T3 ES 91901249 T ES91901249 T ES 91901249T ES 91901249 T ES91901249 T ES 91901249T ES 2084150 T3 ES2084150 T3 ES 2084150T3
Authority
ES
Spain
Prior art keywords
peptides
amino acids
derivative
fats
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91901249T
Other languages
English (en)
Inventor
Robert George Whittaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Application granted granted Critical
Publication of ES2084150T3 publication Critical patent/ES2084150T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

AMINOACIDOS, PEPTIDOS O DERIVADOS DE LOS MISMOS ACOPLADOS A GRASAS LA PRESENTE INVENCION PRESENTA NUEVOS COMPUESTOS EN QUE PEPTIDOS, AMINOACIDOS O DERIVADOS DE LOS MISMOS ESTAN ENLAZADOS A OTRAS MOLECULAS, EN PARTICULAR A ACIDOS GRASOS, LO QUE FACILITA EL USO DE TALES PEPTIDOS, AMINOACIDOS Y DERIVADOS DE LOS MISMOS. LA ESTRUCTURA BASICA DE LOS COMPUESTOS DE LA PRESENTE INVENCION ES UN AMINOACIDO, PEPTIDO O DERIVADO DE LOS MISMOS ENLAZADOS A 1, 2 O 3 MOLECULAS DE UN ACIDO GRASO MEDIANTE UN DERIVADO DE TROMETAMINA. ALTERNATIVAMENTE, EL AMINOACIDO, PEPTIDO O DERIVADO DE LOS MISMOS PUEDE ESTAR ENLAZADO A UN ACIDO GRASO MEDIANTE UN DERIVADO DE ETANOLAMINA.
ES91901249T 1989-12-22 1990-12-19 Aminoacidos, peptidos o sus derivados asociados a las grasas. Expired - Lifetime ES2084150T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPJ803589 1989-12-22

Publications (1)

Publication Number Publication Date
ES2084150T3 true ES2084150T3 (es) 1996-05-01

Family

ID=3774435

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91901249T Expired - Lifetime ES2084150T3 (es) 1989-12-22 1990-12-19 Aminoacidos, peptidos o sus derivados asociados a las grasas.

Country Status (7)

Country Link
EP (1) EP0506748B1 (es)
AT (1) ATE131471T1 (es)
DE (1) DE69024230T2 (es)
DK (1) DK0506748T3 (es)
ES (1) ES2084150T3 (es)
GR (1) GR3018691T3 (es)
WO (1) WO1991009837A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206027A (en) * 1990-09-13 1993-04-27 Fuji Photo Film Co., Ltd. Amphipathic compound and liposome comprising the same
US5554728A (en) * 1991-07-23 1996-09-10 Nexstar Pharmaceuticals, Inc. Lipid conjugates of therapeutic peptides and protease inhibitors
ATE191147T1 (de) * 1991-07-26 2000-04-15 Commw Scient Ind Res Org System der bereitstellung eines impfstoffes auf peptidbasis, das sein eigenes adjuvans bildet, und seine herstellung
SE9302296D0 (sv) * 1993-07-02 1993-07-02 Kabi Pharmacia Ab Amino acid supplement
CA2167818A1 (en) * 1993-08-02 1995-02-09 Robert George Whittaker Therapeutic compound - fatty acid conjugates
EP0788509B1 (en) 1993-08-09 2003-05-28 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Therapeutic peptide derivatives
DE4437502A1 (de) * 1993-12-02 1995-06-08 Basf Ag Hirudin-Konjugate aus Hirudin und lipophilen Verbindungen
AUPM747694A0 (en) * 1994-08-16 1994-09-08 Commonwealth Scientific And Industrial Research Organisation Delivery of nucleic acids and peptides
US5952499A (en) * 1995-01-16 1999-09-14 Commonwealth Scientific And Industrial Research Organisation Therapeutic compound-fatty acid conjugates
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
AUPN741696A0 (en) * 1996-01-05 1996-01-25 Commonwealth Scientific And Industrial Research Organisation Delivery of nucleic acids ii
DE19605175A1 (de) * 1996-02-13 1997-08-14 Sourovoi Andrej Dr Lipidverbindungen und deren Verwendung
US6239108B1 (en) 1996-07-11 2001-05-29 Biogen, Inc. Cell adhesion inhibitors
US6686350B1 (en) 1996-07-25 2004-02-03 Biogen, Inc. Cell adhesion inhibitors
ATE363658T1 (de) 1996-07-25 2007-06-15 Biogen Idec Inc Molekülmodell für vla-4-inhibitoren
AUPP051497A0 (en) * 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
HUP0102255A3 (en) 1998-05-28 2001-12-28 Biogen Idec Ma Inc Cambridge Vla-4 inhibitor omepupa-v, pharmaceutical compositions comprising thereof and their use
GEP20053477B (en) 1999-08-13 2005-03-25 Biogen Inc Cell Adhesion Inhibitors and Pharmaceutical Compositions Containing Them
US6875743B1 (en) 2000-11-28 2005-04-05 Biogen, Inc. Cell adhesion inhibitors
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
MXPA06007043A (es) 2003-12-19 2007-05-23 Univ Melbourne Composicion antimicrobiana.
US7196112B2 (en) 2004-07-16 2007-03-27 Biogen Idec Ma Inc. Cell adhesion inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986004894A1 (fr) * 1985-02-15 1986-08-28 Takeda Chemical Industries, Ltd. Derives de lipides
WO1985004398A1 (fr) * 1984-04-03 1985-10-10 Takeda Chemical Industries, Ltd. Derives de lipides
US4751219A (en) * 1985-02-05 1988-06-14 Nederlandse Centrale Organisatie Voor Toegepast-Natuur-Wetenschappelijk Onderzoek Synthetic glycolipides, a process for the preparation thereof and several uses for these synthetic glycolipides
DE3627924A1 (de) 1986-08-18 1988-03-03 Henkel Kgaa Verwendung von aminofettsaeureamiden als vernetzungsmittel
DE3801587A1 (de) 1988-01-21 1989-08-03 Hoechst Ag Neue aminosaeureglyceride, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
JPH03502328A (ja) * 1988-02-01 1991-05-30 ジ・アップジョン・カンパニー 極性末端基類を有するレニン抑制ペプチド類
GB2217319A (en) * 1988-04-19 1989-10-25 Synpharm Ltd Racemic and optically active fatty amino acids, their homo- abd hetero-oligomers and conjugates, the process of their production, their pharmaceutical composi

Also Published As

Publication number Publication date
DE69024230D1 (de) 1996-01-25
WO1991009837A1 (en) 1991-07-11
EP0506748A4 (en) 1992-12-02
AU649242B2 (en) 1994-05-19
DE69024230T2 (de) 1996-05-02
EP0506748B1 (en) 1995-12-13
ATE131471T1 (de) 1995-12-15
DK0506748T3 (da) 1996-01-22
GR3018691T3 (en) 1996-04-30
AU7033691A (en) 1991-07-24
EP0506748A1 (en) 1992-10-07

Similar Documents

Publication Publication Date Title
ES2084150T3 (es) Aminoacidos, peptidos o sus derivados asociados a las grasas.
BR9107206A (pt) Processo para produzir uma variante de proteina que evoca uma resposta imunogenica diminuida em animais,produtos obtidos,composicao e uso
KR950700728A (ko) 약제형 및 그밖의 다른 복용형(Pharmaceutical and other dosage forms)
ES2179064T3 (es) Procedimiento para la preparacion de lipoproteina reconstituida.
DK0489423T3 (da) Galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelsen af disse forbindelser som lægemidler
SE9100799D0 (sv) Recombinant human factor viii derivatives
MX9200709A (es) Activacion mejorada de proteinas recombinadas. activacion mejorada de proteinas recombinadas.
DE69129899D1 (de) Verfahren zur Herstellung von D-Alpha-Aminosäuren
SE9403526D0 (sv) New Peptides
ES2111000T3 (es) Separacion de proteinas y colorantes.
PT87537A (pt) Process for the preparation of cyclic anticoagulant peptides
MX9302327A (es) Aminoacidos ciclicos novedosos y derivados de los mismos.
ES2196187T3 (es) Conjugados peptidicos derivados de las hormonas timicas, su utilizacion a titulo de medicamento y composiciones que los contienen.
PT87536A (pt) Process for the preparation of cyclic anticoagulant peptides
ES549185A0 (es) Procedimiento para sintetizar peptidos a partir de aminoaci-dos
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
ES2096727T3 (es) Productos cosmeticos y farmaceuticos que contienen extensinas.
DE69032258D1 (de) Antikoagulierende Peptide
ES2077674T3 (es) Aumento de la produccion de proteinas en animales.
AT384032B (de) Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
DE69005451D1 (de) Somatotropinanaloge.
ES2053620T3 (es) Derivados de (2-ciano-2-oximinoacetil)-aminoacidos.
ES2084348T3 (es) N-((4,5-dihidroxi- y 4,5,8-trihidroxi-9,10-dihidro-9,10-dioxo-2-antracen-il)carbonil)aminoacidos utiles en la terapia de afecciones osteoarticulares.
DE68905097D1 (de) Peptid-molekuele, wirksam gegen gram-positive keime.
PT89812A (pt) Processo para a preparacao de uma proteina de endotoxina toxica para insectos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 506748

Country of ref document: ES